ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer
Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the association of zoledronic acid with standard
treatment with anthracycline followed taxane plus trastuzumab in locally advanced breast
cancer HER 2 positive.